FOX vs INBX · P/E 13, $24.49B cap vs rev $1.3M
Fox Corp Class B (FOX) versus Inhibrx Biosciences, Inc. (INBX) — a side-by-side from cached financials, not a winner call.
Fox Corp Class B (FOX) is a entertainment company listed on US.
Inhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.
FOX does not have a complete income-statement cache yet.
Latest reported INBX revenue for 2025-12-31 was $1.3M. Net income was -$140.1M. Revenue was up 550.0% from 2024-12-31 to 2025-12-31. INBX currently screens at market cap $1.28B.
FOX currently screens at market cap $24.49B and trailing P/E 13.0. INBX currently screens at market cap $1.28B.
Not investment advice. Open the FOX and INBX stock pages for the full models.
Not investment advice.